APGAX
Price
$84.10
Change
-$0.15 (-0.18%)
Updated
Apr 17 closing price
Net Assets
23.53B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

APGAX vs VIGRX

Header iconAPGAX vs VIGRX Comparison
Open Charts APGAX vs VIGRXBanner chart's image
AB Large Cap Growth A
Price$84.10
Change-$0.15 (-0.18%)
VolumeN/A
Net Assets23.53B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
APGAX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APGAX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGAX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. APGAX (23.5B). VIGRX pays higher dividends than APGAX: VIGRX (0.39) vs APGAX (0.00). APGAX was incepted earlier than VIGRX: APGAX (33 years) vs VIGRX (32 years). APGAX (0.83) is less costly to investors than VIGRX (0.17). APGAX is a more actively managed with annual turnover of: 30.00 vs. VIGRX (5.00). APGAX has a lower initial minimum investment than VIGRX: APGAX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. APGAX (-5.36). VIGRX return over 5 years is better than : 99.21 vs. APGAX (48.93).
APGAXVIGRXAPGAX / VIGRX
Total Expense Ratio0.820.17482%
Annual Report Gross Expense Ratio0.830.17488%
Fund Existence33 years32 years-
Gain YTD-12.176-14.32685%
Front Load4%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets23.5B261B9%
Annual Yield % from dividends0.000.39-
Returns for 1 year-5.366.01-89%
Returns for 3 years15.1730.3350%
Returns for 5 years48.9399.2149%
Returns for 10 years111.10223.8450%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics